Abstract:Objective To investigate the early diagnosis,prophylaxis and treatment principles of interstitial pneumonia in renal transplant recipients.Methods83 kidney transplant recipients who diagnosed with interstitial pneumonia during the period from 2008 to 2011 in the Urinary Diseases Diagnosis & Treatment Center,First Hospital of Jilin University were enrolled in this study.The difference of prophylaxis,treatment with interstitial pneumonia and the occurrence of interstitial pneumonia after renal transplantation between January- December,2008 and January 2009- December 2011 were compared.Results There were a total of 138 patients underwent allograft renal transplantation during the period from January 2008 to December 2008,and 38 of the kidney recipients developed interstitial pneumonia and the incidence rate was27.54%.There were a total of435patients underwent allograft renal transplantation during the period from January2009to December2011,and45of the kidney recipients developed interstitial pneumonia and the incidence rate was10.34%.Kidney transplant recipients during the period from January2008to December2008received intravenous ganciclovir during the hospital stay and oral ganciclovir in the post-discharge period.Kidney transplant recipients during the period from January2009to December2011 received oral ganciclovir and trimethoprim-sulfamethoxazole(SMZ-TMP)in the post-discharge period according to the plasma concentration and the level of serum creatinine.When diagnosed with interstitial pneumonia by pulmonary CT,the immunosuppressive drugs of the recipients during the period from January2008to December 2008were reduced or withdrew,and corticosteroid therapy,ganciclovir resistant cytomegalovirus(CMV)treatment,combination with the cotrimoxazole antiprotozoal treatment were given.The recipients during the period from January 2009to December2011were received regular high-dose corticosteroid and withdrew the immunosuppressive drugs,given ganciclovir resistant CMV treatment with combination of cotrimoxazole antiprotozoal treatment.In the group of recipients during the period from January2008to December2008,35cases were cured/improved,2cases died,1case abandoned treatment and3cases developed rejection reaction during the treatment period.In the group of recipients during the period from January2009to December2011,45cases were cured/improved,no case died and3 cases developed rejection reaction during the treatment period.There were a total of573patients underwent allograft renal transplantation during the period from2008to2011,among who183patients received antibody induction therapy including basiliximab or antithymocyte globulin(ATG),and the other390patients did not receive.Among83 patients who developed interstitial pneumonia after kidney transplantation,27patients received antibody induction therapy including basiliximab or ATG,while56patients did not receive.ConclusionsEarly discontinuation of immunosuppressive agents and given corticosteroid therapy,ganciclovir resistant CMV treatment,combination the cotrimoxazole antiprotozoal treatment and effective nutrition support therapy were effective in the treatment of interstitial pneumonia after renal transplantation.In addition,under effective medication guide for interstitial pneumonia prevention after renal transplantation,kidney transplant patients' occurrence of interstitial pneumonia was not significantly associated with their use of antibody induction therapy.

Early application of fiberoptic bronchoscopy and bronchoalveolar lavage in patients with pulmonary infection after kidney transplantation

Pharmaceutical Care of Pulmonary Infection After Renal Transplantation

Clinical Analysis of Pulmonary Infections in 25 Patients after Kidney Transplantation

A clinical analysis of post-renal transplant pulmonary infection

Analysis of Eleven Cases of Severe Pneumonia in Kidney Transplant Recipients

The Clinical Diagnosis and Treatment in Pulmonary Infection after Kidney Transplantation

Clinical Features of Pulmonary Infection at Different Stages after Renal Transplantation

Kidney Transplant Recipients with Severe Pulmonary Infection Prevention and Control of Clinical Observation and Experience

[Clinical Study of Pulmonary Infection in Kidney Transplantation Recipients Taking New Immunosuppressant].

Successful Experience of Treatment in Patients with Acute Respiratory Distress Syndrome Caused by Severe Pulmonary Infection Early after Renal Transplantation

The Diagnosis and Treatment of Pulmonary Infection in Patients Accepted Kidney Transplantation Derived from Donation after the Citizen Death (DCD)

Early diagnosis,prophylaxis and treatment of interstitial pneumonia after renal transplantation

Diagnosis and Treatment of Fungal Infection of the Lungs Following Renal Transplantation

A Clinical Study in 178 Kidney Transplant Patients with Infection Disease

Clinical Data and CT Findings of Pulmonary Infection Caused by Different Pathogens after Kidney Transplantation.

Prophylaxis of pulmonary infection by compound sulfamethoxazole combined with ganciclovir in kidney transplant recipients

Clinical Analysis of 98 Cases of Pulmonary Infection in Renal Transplant Recipients

Clinical Analysis of 2520 Renal Transplantations in One Center

Severe Pulmonary Infection after Kidney Transplantation

Effect of Continuous High Volume Hemofiltration on Severe Lung Infection in the Recipients of Renal Transplantation

Pharmaceutical Care for Patients with Pulmonary Infection after Kidney Transplantation